SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-037929
Filing Date
2021-07-21
Accepted
2021-07-21 16:31:38
Documents
49
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_cmlifesciences.htm   iXBRL 10-Q 465138
2 CERTIFICATION f10q0621ex31-1_cmlifescien.htm EX-31.1 17148
3 CERTIFICATION f10q0621ex31-2_cmlifescien.htm EX-31.2 16310
4 CERTIFICATION f10q0621ex32-1_cmlifescien.htm EX-32.1 6259
5 CERTIFICATION f10q0621ex32-2_cmlifescien.htm EX-32.2 6406
  Complete submission text file 0001213900-21-037929.txt   3051600

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cmlf-20210630.xsd EX-101.SCH 44932
7 XBRL CALCULATION FILE cmlf-20210630_cal.xml EX-101.CAL 14740
8 XBRL DEFINITION FILE cmlf-20210630_def.xml EX-101.DEF 175216
9 XBRL LABEL FILE cmlf-20210630_lab.xml EX-101.LAB 322142
10 XBRL PRESENTATION FILE cmlf-20210630_pre.xml EX-101.PRE 178965
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_cmlifesciences_htm.xml XML 317787
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020 212 474 6700
CM Life Sciences, Inc. (Filer) CIK: 0001818331 (see all company filings)

IRS No.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39482 | Film No.: 211104826
SIC: 8000 Services-Health Services